230 related articles for article (PubMed ID: 15797301)
1. Role of computed tomography in the follow-up of hepatic and peritoneal metastases of GIST under imatinib mesylate treatment: a prospective study of 54 patients.
Vanel D; Albiter M; Shapeero L; Le Cesne A; Bonvalot S; Le Pechoux C; Terrier P; Petrow P; Caillet H; Dromain C
Eur J Radiol; 2005 Apr; 54(1):118-23. PubMed ID: 15797301
[TBL] [Abstract][Full Text] [Related]
2. Follow-up of hepatic and peritoneal metastases of gastrointestinal tumors (GIST) under Imatinib therapy requires different criteria of radiological evaluation (size is not everything!!!).
Mabille M; Vanel D; Albiter M; Le Cesne A; Bonvalot S; Le Péchoux C; Terrier P; Shapeero LG; Dromain C
Eur J Radiol; 2009 Feb; 69(2):204-8. PubMed ID: 19046841
[TBL] [Abstract][Full Text] [Related]
3. Cystic changes in intraabdominal extrahepatic metastases from gastrointestinal stromal tumors treated with imatinib.
Kim HC; Lee JM; Choi SH; Han H; Kim SS; Lee SH; Han JK; Choi BI
Korean J Radiol; 2004; 5(3):157-63. PubMed ID: 15467412
[TBL] [Abstract][Full Text] [Related]
4. The clinical characteristics and the role of surgery and imatinib treatment in patients with liver metastases from c-Kit positive gastrointestinal stromal tumors (GIST).
Rutkowski P; Nyckowski P; Grzesiakowska U; Nowecki ZI; Nasierowska-Guttmejer A; Pienkowski A; Dudek K; Krawczyk M; Ruka W
Neoplasma; 2003; 50(6):438-42. PubMed ID: 14689066
[TBL] [Abstract][Full Text] [Related]
5. Cystic changes in hepatic and peritoneal metastases from gastrointestinal stromal tumors treated with Gleevec.
Bechtold RE; Chen MY; Stanton CA; Savage PD; Levine EA
Abdom Imaging; 2003; 28(6):808-14. PubMed ID: 14753595
[TBL] [Abstract][Full Text] [Related]
6. [18F-FDG PET/CT in response evaluation of gastrointestinal stromal tumours treated with imatinib].
Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla JF; Sainz-Esteban A; Barragán J; Portilla-Quattrociocchi H; Carril JM
Rev Esp Med Nucl; 2008; 27(3):168-75. PubMed ID: 18570858
[TBL] [Abstract][Full Text] [Related]
7. Response evaluation in gastrointestinal stromal tumours treated with imatinib: misdiagnosis of disease progression on CT due to cystic change in liver metastases.
Linton KM; Taylor MB; Radford JA
Br J Radiol; 2006 Aug; 79(944):e40-4. PubMed ID: 16861316
[TBL] [Abstract][Full Text] [Related]
8. Effect of angiosonography to monitor response during imatinib treatment in patients with metastatic gastrointestinal stromal tumors.
De Giorgi U; Aliberti C; Benea G; Conti M; Marangolo M
Clin Cancer Res; 2005 Sep; 11(17):6171-6. PubMed ID: 16144917
[TBL] [Abstract][Full Text] [Related]
9. [A case report of two-term surgery for focal progression of a huge liver metastasis and peritoneal dissemination from gastrointestinal stromal tumor during imatinib mesylate treatment].
Toyokawa T; Teraoka H; Kitayama K; Nomura S; Kanehara I; Nishino H
Gan To Kagaku Ryoho; 2014 Mar; 41(3):373-7. PubMed ID: 24743287
[TBL] [Abstract][Full Text] [Related]
10. Imatinib mesylate induces responses in patients with liver metastases from gastrointestinal stromal tumor failing intra-arterial hepatic chemotherapy.
Fiorentini G; Bernardeschi P; Rossi S; Dentico P; Biancalani M; Giustarini G; Turrisi G
J Cancer Res Ther; 2006; 2(2):68-71. PubMed ID: 17998678
[TBL] [Abstract][Full Text] [Related]
11. [Imatinib mesylate alone for refractory advanced gastrointestinal stromal tumor].
Shen L; Jin ML
Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):697-9. PubMed ID: 15777512
[TBL] [Abstract][Full Text] [Related]
12. A treatment using STI571 for jejunal gastrointestinal stromal tumor (GIST) accompanied with liver metastasis and peritoneal dissemination.
Okamoto K; Muguruma N; Aoki R; Sato Y; Nakamoto J; Imoto Y; Okamura S; Ito S; Okitsu H; Sano T
Intern Med; 2004 Dec; 43(12):1151-6. PubMed ID: 15645649
[TBL] [Abstract][Full Text] [Related]
13. The effects of surgical cytoreduction prior to imatinib therapy on the prognosis of patients with advanced GIST.
An HJ; Ryu MH; Ryoo BY; Sohn BS; Kim KH; Oh ST; Yu CS; Yook JH; Kim BS; Kang YK
Ann Surg Oncol; 2013 Dec; 20(13):4212-8. PubMed ID: 24052319
[TBL] [Abstract][Full Text] [Related]
14. A long-term follow-up of the imatinib mesylate treatment for the patients with recurrent gastrointestinal stromal tumor (GIST): the liver metastasis and the outcome.
Zhu J; Yang Y; Zhou L; Jiang M; Hou M
BMC Cancer; 2010 May; 10():199. PubMed ID: 20465813
[TBL] [Abstract][Full Text] [Related]
15. Imaging characteristics of liver metastasis from gastrointestinal stromal tumor before and after imatinib mesylate treatment.
Ulusan S; Koç Z; Kayaselçuk F
Turk J Gastroenterol; 2008 Jun; 19(2):129-32. PubMed ID: 19110671
[TBL] [Abstract][Full Text] [Related]
16. Malignant stromal tumor of the stomach with giant cystic liver metastases prior to treatment with imatinib mesylate.
Colović R; Micev M; Matić S; Colović N; Grubor N; Atkinson HD
Vojnosanit Pregl; 2013 Feb; 70(2):225-8. PubMed ID: 23607193
[TBL] [Abstract][Full Text] [Related]
17. [Successful treatment of huge peritoneal metastasis from duodenal gastrointestinal stromal tumor resistant for imatinib mesylate].
Sakakura C; Kumano T; Mizuta Y; Yamaoka N; Sagara Y; Hagiwara A; Otsuji E
Gan To Kagaku Ryoho; 2007 Nov; 34(12):2144-6. PubMed ID: 18219926
[TBL] [Abstract][Full Text] [Related]
18. Impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib era.
Bonvalot S; Eldweny H; Péchoux CL; Vanel D; Terrier P; Cavalcanti A; Robert C; Lassau N; Cesne AL
Ann Surg Oncol; 2006 Dec; 13(12):1596-603. PubMed ID: 16957966
[TBL] [Abstract][Full Text] [Related]
19. [A case of imatinib-resistant GIST treated by sunitinib].
Sakamoto Y; Akimoto H; Kojo M; Kawano H; Chinen Y; Morita K; Sugiyama M; Saeki H; Minami K; Soejima Y; Sakaguchi Y; Toh Y; Okamura T
Gan To Kagaku Ryoho; 2011 May; 38(5):827-30. PubMed ID: 21566447
[TBL] [Abstract][Full Text] [Related]
20. [Hepatic metastasis from gastric GIST radically resected after imatinib mesylate therapy-a case report].
Kittaka H; Yamada T; Goto K; Ogawa H; Shingai T; Motoori M; Takahashi H; Kishi K; Noura S; Miyashiro I; Ohue M; Ohigashi H; Yano M; Ishikawa O
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2508-10. PubMed ID: 22202429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
